COVID-19 / Coronavirus
Zhongchao Inc. Renews Partnership with Johnson & Johnson (China)
2023-02-23 21:00
3614
SHANGHAI, Feb. 23, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced the renewal of the partnership between Zhongchao Medical Technol...
Trip.com Group aids community recovery through Turkish earthquake relief initiative
2023-02-23 09:00
1953
SHANGHAI, Feb. 23, 2023 /PRNewswire/ -- Trip.com Group, a leading global online travel services provider, is offering aid and assistance to help support victims of the devastatingTurkey-Syria earthquakes that have affected communities throughout the country. Trip.com Group has donated 3,400 eme...
150th Anniversary of Dr. Hansen's Discovery of M. leprae Is Opportunity to Examine Past, Present and Future of Leprosy
2023-02-22 22:00
1934
TOKYO, Feb. 22, 2023 /PRNewswire/ -- The University of Bergen, Norway and Sasakawa Leprosy (Hansen's Disease) Initiative will hold an event inBergen on Feb. 28, 2023, to mark the 150th anniversary of Dr. Gerhard Armauer Hansen's discovery of the leprosy bacillus,M. leprae, in 1873. On the same da...
GenScript ProBio and RVAC Medicines Announce Strategic Partnership for GMP Plasmid DNA Manufacturing for mRNA COVID-19 Vaccine Candidate
2023-02-22 21:00
2230
PISCATAWAY, N.J. and SINGAPORE, Feb. 22, 2023 /PRNewswire/ -- GenScript ProBio, a leading global Contract Development and Manufacturing Organization (CDMO), and RVAC Medicines Pte. Ltd., a biotechnology company focusing on the development and commercialization of messenger RNA (mRNA) therapeu...
AnPac Bio Announces Positive Results from its Multi-Year and Multi-Cancer Test Follow-Up Study
2023-02-22 20:30
2014
NEW YORK, Feb. 22, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (ANPC), a company with operations inthe United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commer...
Commercialization of Gene Therapy is coming soon: Neurophth Completes Patient Enrollment for Phase III clinical trial for the gene therapy treatment of LHON
2023-02-21 21:30
2391
WUHAN, China and SAN DIEGO, Feb. 21, 2023 /PRNewswire/ -- Neurophth Therapeutics, Inc. ("Neurophth") announced today thatthe last patient has been enrolled in the Phase III clinical trial for the treatment of Leber hereditary optic neuropathy (LHON) inChina. It marks the completion of patient enr...
Organizational-level, Unified and Vendor-neutral Enterprise Imaging and Informatics Drive Effective Digital Transformation
2023-02-21 16:12
1814
Scalable enterprise-level solutions leverage all data at an enterprise level and can engage with the entire unified longitudinal patient record SAN ANTONIO, Feb. 21, 2023 /PRNewswire/ -- Medical imaging and healthcare digitalization have seen significant advances and evolution in recent years. T...
RVAC Medicines Secures HSA Approval to Initiate Phase 1B Clinical Trial in Singapore
2023-02-21 10:00
1765
SINGAPORE, Feb. 20, 2023 /PRNewswire/ -- RVAC Medicines Pte. Ltd. (RVAC), a messenger RNA (mRNA) technology platform company, announced today that it has secured the approval from the Health Sciences Authority (HSA) to initiate Phase 1B clinical trial in Singapore to evaluate the safety and immuno...
iGene Laboratory Announces Launch of Whole Exome Sequencing Service
2023-02-21 08:00
2007
SINGAPORE, Feb. 21, 2023 /PRNewswire/ -- Singapore-based molecular diagnostics lab group iGene Laboratory announces the launch of FetalExome test service. FetalExome test is a whole exome sequencing (WES) test available for women with potentially complicated pregnancies. The test examines and a...
Significant Progress Made on the Trivalent Recombinant Protein COVID-19 Vaccine against Subvariants including XBB.1.5 and BA.5 by WestVac Biopharma
2023-02-20 12:43
3195
CHENGDU, China, Feb. 20, 2023 /PRNewswire/ -- Recently, with the support of the National Key R&D Program ofChina, following the clinical trial approval for Recombinant Variant COVID-19 Vaccine (Sf9 cell) approved by NMPA, WestVac Biopharma (Guangzhou) Co., Ltd. (hereinafter referred to as "WestVa...
CGTN: China achieves 'major, decisive' victory in COVID-19 response: CPC leadership
2023-02-17 15:27
3092
BEIJING, Feb. 17, 2023 /PRNewswire/ -- Over the past three years, China has always been putting people's lives and health first and adapting its COVID-19 response in light of the evolving situation, in efforts widely believed to have bought precious time for a smooth transition. The country has ...
Qilian International Holding Group Ltd Declares Special Cash Dividends to Shareholders
2023-02-17 05:30
3171
JIUQUAN, China, Feb. 16, 2023 /PRNewswire/ -- Qilian International Holding Group Ltd (the "Company" or Nasdaq: QLI), aChina-based pharmaceutical and chemical products manufacturer, announced today that the Company has declared a special one-time cash dividend of$0.05 per ordinary share, payable i...
Immuno Cure kick off Phase I Clinical Trial in Shenzhen
2023-02-16 20:36
4669
A significant step for developing our PD-1-Enhanced DNA Vaccine against HIV/AIDS HONG KONG, Feb. 16, 2023 /PRNewswire/ -- Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in PD-1-Enhanced DNA vaccines and immunotherapies,announced the ...
Alibaba Entrepreneurs Fund Launches JUMPSTARTER 2023 Global Pitch Competition
2023-02-16 18:23
2879
Newly added HKD1 million cash prize and a maximum total investment of up to USD5 million Encourage start-ups to integrate UN Sustainable Goals into businesses HONG KONG, Feb. 16, 2023 /PRNewswire/ -- Alibaba Hong Kong Entrepreneurs Fund ("AEF") today announced the JUMPSTARTER 2023 Global Pitch C...
Oral Presentation at APASL Annual Meeting 2023 Demonstrates ASC22, a Subcutaneous PD-L1 Antibody, Can Achieve Functional Cure of Chronic Hepatitis B
2023-02-16 17:10
2806
HANGZHOU and SHAOXING, China, Feb. 16, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") today announces that the oral presentation at the 2023 annual meeting of the Asian Pacific Association for the Study of the Liver ("APASL Annual Meeting 2023") demonstrates that ASC22 (Envafol...
AnPac Bio-Medical Science Acquires GISN (HK) LIMITED, a Technical Solution and Outsourcing Consulting Services Provider
2023-02-15 21:00
3232
NEW YORK, Feb. 15, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations inthe United States andChina focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platfo...
GILEAD TO PRESENT DATA AT APASL 2023 ON EFFECTIVE MODELS FOR MONITORING AND TREATING HEPATITIS C AND EFFICACY OF ANTIVIRAL TREATMENTS FOR HIV-1 AND HBV-COINFECTED ADULTS
2023-02-15 10:00
2384
- Study recommends a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus (HCV) infection with DAA Therapies - Review of implementation science projects toward HCV Elimination by 2030 in Asia proved effective in improving patient outcomes - Efficacy ...
Waterdrop CEO Peng Shen Elected as a Member of the School Affairs Council of HKU Business School
2023-02-14 21:32
3493
BEIJING, Feb. 14, 2023 /PRNewswire/ -- On February 9, HKU Business School announced the new membership list for the School Affairs Council. After nomination and voting by HKU Business School's alumni and publicity by the school,Peng Shen, Founder and CEO of Waterdrop, was elected as a member of t...
CJ FNT was Globally Launched to Become a 'Total Solutions Provider' in the Food & Nutrition Market
2023-02-14 21:00
2027
- Synergizing the bio and food business competencies to target the global market for food & nutritional ingredient solutions SEOUL, South Korea, Feb. 14, 2023 /PRNewswire/ -- CJ Food&Nutrition Tech (CJ FNT), a newly established business unit withinSouth Korea-based food & bio company CJ CheilJed...
AnPac Bio-Medical Science Enters into Definitive Agreement to Make Another Acquisition to Significantly Expand Scope of Business in the U.S.
2023-02-13 21:00
3414
NEW YORK, Feb. 13, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations inthe United States andChina announced that on February 12, 2023, the Company, through its subsidiary Foodbase Group Inc., entered into a definitive equity purchas...
Week's Top Stories
Most Reposted
MediThinQ Unveils SCOPEYE 3D Micro Surgery Solution; Chris Lee of VentureBlick Assumes Chairmanship
[Picked up by 331 media titles]
2024-05-23 10:00SINGAPORE'S XSQUARE TECHNOLOGIES SECURES S$10.5M IN SERIES A FUNDING LED BY WAVEMAKER PARTNERS
[Picked up by 326 media titles]
2024-05-23 10:00Samsung Electronics Unveils Month-Long Celebration of Esports Events for Students in Southeast Asia
[Picked up by 320 media titles]
2024-05-21 08:00Mitsui Bussan Secure Directions, Inc. launches Blackpanda IR Retainer, a cyber incident emergency response retainer service
[Picked up by 312 media titles]
2024-05-21 13:00Unlock the Future of Innovation: Taiwan's Premier Hardware Expo Hits the Global Stage This October
[Picked up by 312 media titles]
2024-05-24 09:41Most Read
Revolutionising Cardiac Care at Pantai Hospital Kuala Lumpur
2024-05-23 11:22
9409